{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:09:42Z","timestamp":1792066182694,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009783","name":"S:t Eriks \u00d6gonforskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["20 0798 Fk"],"award-info":[{"award-number":["20 0798 Fk"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcjo.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:29:11Z","timestamp":1778243351000},"page":"1181-1190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thirty-year visual acuity outcomes after plaque brachytherapy for posterior uveal melanoma"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-4284","authenticated-orcid":false,"given":"Lauren A.","family":"Dalvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8911","authenticated-orcid":false,"given":"Gustav","family":"St\u00e5lhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2026.04.006_bib0001","doi-asserted-by":"crossref","first-page":"pkad097","DOI":"10.1093\/jncics\/pkad097","article-title":"Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death","volume":"7","author":"Stalhammar","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/eye.2012.126","article-title":"Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture","volume":"26","author":"Damato","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0003","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","article-title":"Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review","volume":"17","author":"Le","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brachy.2015.09.013","article-title":"Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy","volume":"15","author":"Wisely","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0007","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2008.12.027","article-title":"Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients","volume":"116","author":"Finger","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0008","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.prro.2013.08.004","article-title":"Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma","volume":"4","author":"Takiar","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0009","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.prro.2014.09.005","article-title":"A choice of radionuclide: comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma","volume":"5","author":"Takiar","year":"2015","journal-title":"Pract Rad Oncol"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(02)01181-8","article-title":"Plaque radiotherapy for large posterior uveal melanomas (>or =8-mm thick) in 354 consecutive patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0011","article-title":"A prognostic score for the prediction of local treatment failure in plaque brachytherapy of uveal melanoma","volume":"8","author":"Kal Omar","year":"2023","journal-title":"Adv Rad Oncol"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23447","article-title":"Incidence, risk factors and outcomes of cataract surgery after plaque brachytherapy for posterior uveal melanoma","volume":"10","author":"Gill","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0013","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/PL00007880","article-title":"Long-term follow-up of Ru-106\/Rh-106 brachytherapy for posterior uveal melanoma","volume":"238","author":"Lommatzsch","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jclinepi.2015.07.006","article-title":"Competing risk bias was common in Kaplan\u2013Meier risk estimates published in prominent medical journals","volume":"69","author":"van Walraven","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0015","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/s41433-022-02316-8","article-title":"The prognostic implication of visual acuity at the time of uveal melanoma diagnosis","volume":"37","author":"Asplund","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0016","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.brachy.2021.05.162","article-title":"Long-term outcomes after enucleation or plaque brachytherapy of choroidal melanomas touching the optic disc","volume":"20","author":"Fili","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0017","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ijrobp.2023.06.077","article-title":"Brachytherapy with 15 versus 20 mm ruthenium-106 plaques without verification of plaque position is associated with local tumor recurrence and death in posterior uveal melanoma","volume":"117","author":"Stalhammar","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jcjo.2026.04.006_bib0018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0161-6420(96)30680-5","article-title":"Useful visual outcomes after treatment of Bacillus cereus endophthalmitis","volume":"103","author":"Foster","year":"1996","journal-title":"Ophthalmology"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:31:39Z","timestamp":1788982299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418226001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0008418226001481"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.04.006","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thirty-year visual acuity outcomes after plaque brachytherapy for posterior uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}